维普中文期刊产品整合服务
88篇 您的检索式:作者名="Gajewski TF"
    题名 作者 年代 出处 被引量
1On the TRAIL toward death receptor based cancer ther- apeutics显示文摘Gajewski TF 2007J Clin 0ncol2007,25,:1
2Immune suppression inthe tumor microenvironment显示文摘Gajewski TF Meng Y Harlin H 2006J Immunother2006,29,3:1
3Immunization lf HLA-A2+ melanoma patients with MAGE-3 or Melan A peptide-pulsed autologous peripheral blood mononuclear cells plus recombinant human interleukin 12显示文摘Gajewski TF Fallarino F Ashikari A 2001Clin Caner Tes2001,7,3:1
4Failure at the effector phase: immue barriers at the level of the melanoma tumor microenvironment 显示文摘Gajewski TF 2007Clin Cancer Res2007,13,:1
5Innate and adaptive immune cells in the tumor micreenvirenment 显示文摘Gajewski TF Schreiber H Fu YX 2013Nat Immunol2013,14,10:1
6On the TRAIL toward death receptor-based cancer therapeutics显示文摘Gajewski TF 0,,11:1
7lrlomeostatic proliferation plus regulatory T cell depletion promotes potent rejection of B16 melanoma显示文摘Kline J Brown IE Zha YY Blank C Strickler J Wouters H Zhang L Gajewski TF 2008Clin Cancer Res2008,14,:1
8Negative regulation of T-cell function by PD-1显示文摘Zha YY Blank C Gajewski TF 2004Critical Reviews in Immunolo-gy2004,24,4:1
9Negative regulation of T-cell function by PD-1 显示文摘Zha Y Blank C Gajewski TF 2004Crit Rev Immunol2004,24,4:1
10Immune suppression in the tumor microenvironment 显示文摘Gajewski TF Meng Y Harlin H 2006J Immunother2006,29,3:1
11Apoptosis meets signal transduction: elimination of a BAD influence显示文摘Gajewski TF Thompson CB 1996Cell1996,87,4:1
12A muhicenter, open-la- bel trial of talimogene laherparepvec(T-VEC) plus pembrolizum- ab vs pembrolizumab monotherapy in previously untreated, unre- sected, stage ⅢB-Ⅳmelanoma显示文摘Ribas A Puzanov I Gajewski TF 2015J Clin Oncol2015,33,15:1
13Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment显示文摘Gajewski TF 2007Clin Cancer Res2007,13,18:1
14The STING pathway andthe T cell-inflamed tumor microenvironment 显示文摘Woo SR Corrales L Gajewski TF 2015Trends Immu-nol2015,36,4:1
15An adenoviral vector encoding dominantnegative Cbl lowers the threshold for T cell activation in post-thymic T cells显示文摘Zha Y’Gajewski TF 2007Cell Immunol2007,247,2:1
16Irsrsune suppression in the tumor microenvironment显示文摘 Meng Y Hadin H 2006J Immunother2006,29,3:1
17Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment显示文摘Gajewski TF Fuertes M Spaapen R 2011Curr Opin Immunol2011,23,2:1
18Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion:implications for tumor immunotherapy显示文摘Blank C Gajewski TF Mackensen A 2005Cancer Immunol Immunother2005,54,4:1
19The expading universe of regulatory T cell subwets in cancer 显示文摘Gajewski TF 2007Immunity2007,27,2:1
20B7 - 1 but not B7 - 2 efficiently costimulates CD8 + T lymphocytes in the P815 tumor system in vitro显示文摘Gajewski TF 1996J Immunol1996,,:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费